Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 1:15:1539215.
doi: 10.3389/fonc.2025.1539215. eCollection 2025.

The association between nutritional risk and survival time among patients with pancreatic cancer following pancreaticoduodenectomy: a retrospective cohort study

Affiliations

The association between nutritional risk and survival time among patients with pancreatic cancer following pancreaticoduodenectomy: a retrospective cohort study

Qiuju Tian et al. Front Oncol. .

Abstract

Background: Nutritional problems are common in patients with pancreatic cancer. However, the relationship between nutritional risk screening and the survival of patients after pancreaticoduodenectomy remains inconclusive. This study aimed to examine the association between preoperative nutritional risk and survival time among adult Chinese patients with pancreatic cancer after pancreaticoduodenectomy.

Methods: This study was conducted at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine in China. Patients aged 18 years or more who received pancreaticoduodenectomy for pancreatic cancer in our center between December 2019 and June 2022 from the follow-up database were included in the study. We retrospectively collected data on the demographics, disease, treatment, nutritional risk score, and survival time of the patients with pancreatic cancer. A Cox regression model was used to analyze the association between nutritional risk and survival time in different covariate models.

Results: A total of 656 patients were included in the study, and the median survival time was 24.0 months (95% CI:21.6-26.3). In total, 29.1% of patients had nutritional risk on admission. At the end of the follow-up, a total of 364 (55.5%) patients had died. The overall 1-, 2-, and 3-year survival rate of the 656 patients with pancreatic cancer after pancreaticoduodenectomy was 72.7%, 49.8%, and 34.4%, respectively. In the Cox regression model adjusted for age, education level, carbohydrate antigen 199 levels, neutrophil-lymphocyte ratio, tumor diameter, lymph node metastasis, distant organ metastasis, differentiation, nerve invasion, surgical margins, surgical time, intraoperative blood loss, postoperative complications, and chemotherapy, patients with nutritional risk score greater than 3 had a lower survival time compared with those without nutritional risk (HR = 1.33, 95% CI:1.06-1.67; P = 0.015).

Conclusions: Preoperative nutritional risk has a detrimental impact on survival in patients with pancreatic cancer who undergo pancreaticoduodenectomy, and this relationship is stable. Nursing staff should screen early for nutritional risk using the Nutritional Risk Screening-2002 tool in patients with pancreatic cancer at diagnosis and, in conjunction with their doctors, develop and implement a timely nutritional treatment plan for those at risk to improve the poor survival time.

Keywords: nutritional risk; pancreatic cancer; pancreaticoduodenectomy; screening; survival.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Comparison of the survival time of 656 patients with different NRS-2002 scores: <3 or >=3.

Similar articles

References

    1. Ren S, Song L, Tian Y, Zhu L, Guo K, Zhang H, et al. Emodin-conjugated PEGylation of Fe(3)O(4) nanoparticles for FI/MRI dual-modal imaging and therapy in pancreatic cancer. Int J Nanomed. (2021) 16:7463–78. doi: 10.2147/ijn.S335588 - DOI - PMC - PubMed
    1. Cao YY, Guo K, Zhao R, Li Y, Lv XJ, Lu ZP, et al. Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma. Digital Health. (2023) 9:20552076231179007. doi: 10.1177/20552076231179007 - DOI - PMC - PubMed
    1. Ren S, Qian LC, Cao YY, Daniels MJ, Song LN, Tian Y, et al. Computed tomography-based radiomics diagnostic approach for differential diagnosis between early- and late-stage pancreatic ductal adenocarcinoma. World J Gastrointest Oncol. (2024) 16:1256–67. doi: 10.4251/wjgo.v16.i4.1256 - DOI - PMC - PubMed
    1. Torphy RJ, Fujiwara Y, Schulick RD. Pancreatic cancer treatment: better, but a long way to go. Surg Today. (2020) 50:1117–25. doi: 10.1007/s00595-020-02028-0 - DOI - PMC - PubMed
    1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA: Cancer J Clin. (2024) 74:12–49. doi: 10.3322/caac.21820 - DOI - PubMed

LinkOut - more resources